TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19904293

Group type: EXPERIMENTAL
Intervention: Iron supplementation alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (separately or together with iron)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined zinc and iron supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined iron and zinc supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc and iron supplementation (together or separately)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Separate delivery of iron and zinc
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Separate and combined administration of iron and zinc
Number of subjects: 0
Study: 17678782

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% with 5 doses each side, total dosage 40 mL (300 mg) via parasternal intercostal injection
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 88

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 88
Study: 15765326

Group type: EXPERIMENTAL
Intervention: Morphine (0.1 mg/kg initial IV injection, then 3 mg every 5 minutes)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Fentanyl (1 microg/kg initial IV injection, then 30 microg every 5 minutes)
Number of subjects: 54
Study: 11510921

Group type: EXPERIMENTAL
Intervention: Heparin coated circuits combined with leukocyte filtration (group I)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 52
Study: 9764623

Group type: EXPERIMENTAL
Intervention: i.v. hypotonic fluid
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: oral water
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: i.v. isotonic fluid
Number of subjects: 84

Group type: COMPARATOR
Intervention: control
Number of subjects: 84
Study: 7844228

Group type: EXPERIMENTAL
Intervention: Previous successful IVF trials (Group A)
Number of subjects: 257

Group type: COMPARATOR
Intervention: New IVF patients (Group B)
Number of subjects: 257
Study: 3802722

Group type: EXPERIMENTAL
Intervention: Cough test after pharmacological autonomic blockade (atropine)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cough test in diabetic patients with autonomic neuropathy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cough test in healthy subjects
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intense contraction of arm muscles (handgrip)
Number of subjects: 8
Study: 30015069

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention package including detection, treatment, and control of cardiovascular risk factors by nonphysician health workers, free dispensation of combination antihypertensive and cholesterol-lowering medications, and support from a treatment supporter.
Number of subjects: 1376

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1376

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention package.
Number of subjects: 1376
Study: 27036491

Group type: EXPERIMENTAL
Intervention: Heat therapy
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Contrast therapy
Number of subjects: 115
Study: 24149850

Group type: EXPERIMENTAL
Intervention: Training group (T) - simulation-based training
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (C) - standard residency training
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Training group (T) - final total GOALS‐GH scores
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (C) - final total GOALS‐GH scores
Number of subjects: 17
Study: 23273776

Group type: EXPERIMENTAL
Intervention: 12-week contingency management (CM) intervention for stimulant abuse
Number of subjects: 96
Study: 21470279

Group type: EXPERIMENTAL
Intervention: 20% lipid/heparin infusion (LHI)
Number of subjects: 13

Group type: COMPARATOR
Intervention: saline/heparin infusion (SHI)
Number of subjects: 13
Study: 18282679

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) support targeting physical activity and nutrition weight loss strategies
Number of subjects: 77

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 77
Study: 16434754

Group type: COMPARATOR
Intervention: Saline before and after surgery (Group 1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Ketamine 300 microg x kg(‐1) iv before and saline after surgery (Group 2)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Saline before and ketamine 300 microg x kg(‐1) iv after surgery (Group 3)
Number of subjects: 84
Study: 12844250

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex) 8 mg administered on days 2-4 after chemotherapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dexamethasone (Dex)
Number of subjects: 70
Study: 11106119

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m2 on days 1-8 plus cisplatin 100 mg/m2 (arm A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m2 on days 1-8 plus cisplatin 70 mg/m2 (arm B)
Number of subjects: 88
Study: 9574357

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 90
Study: 8225671

Group type: EXPERIMENTAL
Intervention: Streptokinase and adjunctive angioplasty
Number of subjects: 206
Study: 6873872

Group type: EXPERIMENTAL
Intervention: Intravenous cimetidine (300 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral cimetidine (300 mg every 8 hours for 8 days)
Number of subjects: 20
Study: 30260748

Group type: EXPERIMENTAL
Intervention: Diabetic sesame oil (DSO)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Diabetic control (DCON)
Number of subjects: 46
Study: 29734881

Group type: EXPERIMENTAL
Intervention: Ubiquinol (200 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 27321122

Group type: EXPERIMENTAL
Intervention: ALA-DAG (2.5 g/d)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control triacylglycerol (TAG) (2.5 g/d)
Number of subjects: 184
Study: 23070695

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) intervention
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 19
Study: 22206631

Group type: EXPERIMENTAL
Intervention: High attendance class
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Descending class
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Early-drop class
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Rising class
Number of subjects: 1825

Group type: EXPERIMENTAL
Intervention: Low and no classes
Number of subjects: 1825
Study: 18951439

Group type: EXPERIMENTAL
Intervention: Botox (BOT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dysport (DYS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Botox (BOT) and Dysport (DYS)
Number of subjects: 18
Study: 17416761

Group type: COMPARATOR
Intervention: HPV-6
Number of subjects: 360

Group type: COMPARATOR
Intervention: HPV-11
Number of subjects: 360

Group type: COMPARATOR
Intervention: HPV-16
Number of subjects: 360

Group type: COMPARATOR
Intervention: HPV-18
Number of subjects: 360
Study: 16329657

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15037535

Group type: EXPERIMENTAL
Intervention: Walnut diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 21
Study: 10729719

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS) during heelstick procedures
Number of subjects: 26

Group type: COMPARATOR
Intervention: Heelstick procedures without NNS
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS)
Number of subjects: 26
Study: 8871871

Group type: COMPARATOR
Intervention: IFN 5 MU, three times weekly by subcutaneous injection alone (n = 14)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: IFN 5 MU in combination with cycles of deferoxamine at a dose of 80 mg kg‐1 per cycle (n = 13)
Number of subjects: 27
Study: 1799151

Group type: EXPERIMENTAL
Intervention: Cefotiam (2 g intravenously with induction of anaesthesia)
Number of subjects: 711

Group type: COMPARATOR
Intervention: Control (no cefotiam)
Number of subjects: 711
Study: 6849542

Group type: EXPERIMENTAL
Intervention: High dose corticosteroids (2 g methylprednisolone intravenously once a week plus 0.25 mg/kg prednisone orally daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low dose corticosteroids (0.25 mg/kg prednisone orally daily)
Number of subjects: 13
Study: 31124400

Group type: EXPERIMENTAL
Intervention: Randomized response technique
Number of subjects: 0
Study: 31034349

Group type: EXPERIMENTAL
Intervention: In-office bleaching with high hydrogen peroxide concentration (Opalescence Boost PF 40%, Ultradent) for 40 minutes in three sessions (first, eighth, and 15th days of treatment)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: At-home bleaching with low carbamide peroxide concentration (Opalescence PF 10%, Ultradent) for 60 minutes daily for 15 days
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (no bleaching agent applied)
Number of subjects: 135
Study: 27631892

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (three session nurse-led program)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 155
Study: 26480904

Group type: EXPERIMENTAL
Intervention: Vibrotactile stimulus from Vertiguard™ for ten days
Number of subjects: 13

Group type: COMPARATOR
Intervention: Equipment without the stimulus (Control Group)
Number of subjects: 13
Study: 23635680

Group type: EXPERIMENTAL
Intervention: Immediate scan after urination (within 5 minutes)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Deferred scan (at least 15 minutes after urination)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 221
Study: 21670177

Group type: EXPERIMENTAL
Intervention: Dispersible tablet
Number of subjects: 184

Group type: COMPARATOR
Intervention: Crushed tablet
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 184
Study: 18811878

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP), 500 microg twice daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16611285

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. for 7 days
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Lactoferrin 200 mg b.d. for 7 days followed by the same schedule of group A
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg b.d., clarithromycin 500 mg b.d. and tinidazole 500 mg b.d. plus lactoferrin 200 mg b.d. for 7 days
Number of subjects: 402
Study: 14557443

Group type: EXPERIMENTAL
Intervention: iv OXM (3.0 pmol/kg.min)
Number of subjects: 13
Study: 11326143

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 30)
Number of subjects: 60
Study: 8855804

Group type: EXPERIMENTAL
Intervention: T enanthate 200 mg im every 20 days
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sublingual T cyclodextrin (SLT) 2.5 mg three times daily
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sublingual T cyclodextrin (SLT) 5.0 mg three times daily
Number of subjects: 51
Study: 1535876

Group type: EXPERIMENTAL
Intervention: Low‐osmolality contrast medium (LOM)
Number of subjects: 929

Group type: COMPARATOR
Intervention: High‐osmolality contrast medium (HOM)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Low‐osmolality contrast medium (LOM) in angiocardiography
Number of subjects: 929

Group type: COMPARATOR
Intervention: High‐osmolality contrast medium (HOM) in angiocardiography
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Low‐osmolality contrast medium (LOM) in body CT
Number of subjects: 929

Group type: COMPARATOR
Intervention: High‐osmolality contrast medium (HOM) in body CT
Number of subjects: 929
Study: 6441778

Group type: EXPERIMENTAL
Intervention: 3 types of hypocaloric parenteral nutrition (75 g/day amino acids with different carbohydrates: 120 g dextrose, 120 g or 200 g dextrose/fructose/xylitol)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving 75 g/day of dextrose
Number of subjects: 40
Study: 31919514

Group type: EXPERIMENTAL
Intervention: HE‐HFD (hyperenergetic, high‐fat diet; +50% energy, 65% total energy as fat)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HE‐HFD (hyperenergetic, high‐fat diet)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control diet (36% total energy as fat)
Number of subjects: 12
Study: 31006805

Group type: EXPERIMENTAL
Intervention: Whole pinto beans (wPB) supplemented into HSF diet (5% wt:wt)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Hulls of pinto beans (hPB) supplemented into HSF diet (0.5% wt:wt)
Number of subjects: 44

Group type: COMPARATOR
Intervention: High saturated fat diet (HSF)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal-fat diet (NF)
Number of subjects: 44
Study: 28538321

Group type: EXPERIMENTAL
Intervention: Partial back squat
Number of subjects: 15

Group type: COMPARATOR
Intervention: Full back squat
Number of subjects: 15
Study: 27265097

Group type: EXPERIMENTAL
Intervention: 30-minute therapist-delivered brief intervention (Project Sync)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) condition (resource brochure)
Number of subjects: 409
Study: 25135191

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 626
Study: 22712624

Group type: EXPERIMENTAL
Intervention: Test group (graft positioned 1 mm apical to CEJ, flap 1 mm coronal to CEJ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (graft and flap positioned at the level of CEJ)
Number of subjects: 15
Study: 19295270

Group type: EXPERIMENTAL
Intervention: Oral cavity care patient guidance including teaching good brushing methods, O'Leary's Plaque Control Record (PCR) as a cleanliness index, and Eilers' Oral Assessment Guide (OAG) as an overall index after April 2006
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral cavity care patient guidance
Number of subjects: 20
Study: 18021525

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) for 20 min per session, 5 days weekly for 6 weeks.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standardized functional exercise program (Control group).
Number of subjects: 78
Study: 15667867

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 11139532

Group type: EXPERIMENTAL
Intervention: 600 microgram misoprostol
Number of subjects: 2058

Group type: COMPARATOR
Intervention: 1 ml syntometrine
Number of subjects: 2058
Study: 9617377

Group type: EXPERIMENTAL
Intervention: Combination of higher dose metoclopramide (3 mg/kg x2) plus dexamethasone and diphenhydramine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonist plus dexamethasone
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Optimal antiemetic prophylaxis for delayed emesis induced by moderately emetogenic chemotherapy
Number of subjects: 70
Study: 7875420

Group type: EXPERIMENTAL
Intervention: Enprostil
Number of subjects: 165

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 165
Study: 2453704

Group type: EXPERIMENTAL
Intervention: Allopurinol 250-500 mg/m2 body surface
Number of subjects: 0
Study: 31738463

Group type: EXPERIMENTAL
Intervention: PARO intervention (robotic seal), 30 minutes, 5 days a week for 6 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: PARO intervention (robotic seal)
Number of subjects: 11
Study: 29653629

Group type: EXPERIMENTAL
Intervention: Oral doxycycline (100 mg once a day for 28 days)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Oral doxycycline
Number of subjects: 1000
Study: 28159821

Group type: EXPERIMENTAL
Intervention: 20 minutes hemostatic compression time
Number of subjects: 568

Group type: COMPARATOR
Intervention: 60 minutes hemostatic compression time
Number of subjects: 568
Study: 26216371

Group type: EXPERIMENTAL
Intervention: Transvenous leads implantation and right ventricular (RV) pacing
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: High frequency of RV pacing (>40%)
Number of subjects: 206
Study: 23937708

Group type: EXPERIMENTAL
Intervention: Nightly sildenafil (50 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: On-demand sildenafil (50 mg)
Number of subjects: 100
Study: 20086023

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18234466

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.5 mg/kg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Unfractionated heparin (5000 IU)
Number of subjects: 160
Study: 16490582

Group type: EXPERIMENTAL
Intervention: Extended-release hydromorphone hydrochloride (ER hydromorphone HCl) administered every 24 hours
Number of subjects: 343

Group type: COMPARATOR
Intervention: Immediate-release hydromorphone hydrochloride (IR hydromorphone HCl) tablets as rescue medication
Number of subjects: 343
Study: 12746764

Group type: EXPERIMENTAL
Intervention: Intravenous diphenhydramine administration
Number of subjects: 64

Group type: COMPARATOR
Intervention: Liposomal amphotericin B (L-AMB) infusion
Number of subjects: 64
Study: 10952475

Group type: EXPERIMENTAL
Intervention: Zaleplon 20 mg alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Thioridazine 50 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Zaleplon 20 mg and Thioridazine 50 mg coadministration
Number of subjects: 12
Study: 9282974

Group type: EXPERIMENTAL
Intervention: Crohn's disease patients
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 36
Study: 8337731

Group type: COMPARATOR
Intervention: Intramuscular QN alone (quinine dihydrochloride 20 mg salt/kg as a loading dose, followed by 10 mg salt/kg 12 hourly for a total of 6 doses)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intramuscular QN plus one intramuscular injection of SD/PM (sulfadoxine 25 mg/kg, pyrimethamine 1.25 mg/kg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SD/PM
Number of subjects: 80
Study: 3806204

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (1-(2-chloroethyl)-1-nitrosourea, vincristine, and prednisone)
Number of subjects: 74

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 74
Study: 31476757

Group type: EXPERIMENTAL
Intervention: Resin infiltration application + fluoridated toothpaste and flossing use
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fluoridated toothpaste and flossing use
Number of subjects: 41
Study: 31197822

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) with an OTT of 7 days (group A)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Short-course radiotherapy (5 × 5 Gy) with an OTT of 8-13 days (group B)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) with an OTT of 5-7 weeks (group C)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) with an OTT of 8-13 weeks (group D)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Long-course radiotherapy (25 × 2 Gy) with an OTT of 9-11 weeks (group E)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Long-course radiotherapy (25 × 2 Gy) with an OTT of 12-14 weeks (group F)
Number of subjects: 810
Study: 28741871

Group type: EXPERIMENTAL
Intervention: RG7697 (0.03 to 5 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: RG7697 (≥1.8 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: RG7697
Number of subjects: 51
Study: 26383102

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 3604

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 3604
Study: 24225972

Group type: EXPERIMENTAL
Intervention: Internet-based self-help intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Internet-based intervention with 3 supplemental counseling sessions
Number of subjects: 58
Study: 22360134

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) continuous regimen: 1,000 AU/week for the entire study period (Group 1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) pre-seasonal regimen: 5,000 AU/week for 10 weeks/year for 2 years (Group 2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: On demand drug therapy alone (Group 3)
Number of subjects: 32
Study: 19666432

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Methimazole (MMZ)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both PTU and MMZ
Number of subjects: 50
Study: 17940869

Group type: EXPERIMENTAL
Intervention: Knowledge of HBV risk among Chinese Americans
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Doctor recommendation for HBV testing
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Asking a doctor for the HBV test
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Need for interpreter services
Number of subjects: 442
Study: 15065962

Group type: EXPERIMENTAL
Intervention: Structural Ecosystems Therapy (SET)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Attention-comparison person-centered condition
Number of subjects: 209

Group type: COMPARATOR
Intervention: Community control condition
Number of subjects: 209
Study: 11265008

Group type: EXPERIMENTAL
Intervention: Femoral neck stress fractures group
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (fifteen patients undergoing iliac crest bone grafting for scaphoid nonunions)
Number of subjects: 23
Study: 9539069

Group type: EXPERIMENTAL
Intervention: rhGH (0.3 IU/kg per day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 8008325

Group type: EXPERIMENTAL
Intervention: Azithromycin, 1 g orally as one dose
Number of subjects: 30

Group type: COMPARATOR
Intervention: Erythromycin, 500 mg orally four times a day for 7 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Erythromycin, 500 mg orally four times a day for 7 days (initial dosage)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Erythromycin, 250 mg orally four times a day (adjusted dosage)
Number of subjects: 30